Late life depression with cognitive impairment: Evaluation and treatment

Clinical Interventions in Aging

Volumn 4, Issue 1, 2009, Pages 51-57

  Wilkins, Consuelo H ^a,b   Mathews, Jose ^b   Sheline, Yvette I ^b  

^a Department of Medicine   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; Cognitive impairment; Diagnosis; Late life depression; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ACUTE DISEASE; ALCOHOL CONSUMPTION; ANOREXIA; BLOOD PRESSURE; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CEREBROVASCULAR DISEASE; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEATH; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG USE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; LATE LIFE DEPRESSION; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR DEPRESSION; MARRIAGE; MINI MENTAL STATE EXAMINATION; NAUSEA; PATHOPHYSIOLOGY; PATIENT HEALTH QUESTIONNAIRE 9; PHOTOSENSITIVITY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RECURRENT DISEASE; RELAPSE; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL ISOLATION; THE GERIATRIC DEPRESSION SCALE; UNSPECIFIED SIDE EFFECT; VOMITING;

AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; MALE; PSYCHOLOGY;

EID: 66249135633     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life: consensus statement update. JAMA. 1997;278:1186-90.
2. Teresi J, Abrams R, Holmes D, et al. Prevalence of depression and depression recognition in nursing homes. Soc Psychiatry Psychiatr Epidemiol. 2001;36:613-20.
3. Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: The role of stress and medical comorbidity. Biol Psychiatry. 2000;48:791-800.
4. Sheline YI, Wang PW, Gado MH, et al. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 1996;93:3908-13.
5. Taylor WD, Steffens DC, MacFall JR, et al. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry. 2003;60:1090-6.
6. Figiel GS, Krishnan KRR, Doraiswamy PM, et al. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging. 1991;12:245-7.
7. Lyness JM, Caine ED, Cox C, et al. Cerebrovascular risk factors and later-life major depression: Testing a small-vessel brain disease model. Am J Geriatr Psychiatry. 1998;6:5-13.
8. Kramer-Ginsberg E, Greenwald BS, Krishnan KR, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry. 1999;156:438-44.
9. Heiden A, Kettenbach J, Fischer P, et al. White matter hyperintensities and chronicity of depression. J Psychiatr Res. 2005;39:285-93.
10. O'Brien JT, Firbank MJ, Krishnan MS, et al; on behalf of the LADIS Group. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: The LADIS study. Am J Geriatr Psychiatry. 2006;14:834-41.
11. Bennett DA, Wilson RS, Schneider JA, et al. Cerebral infarctions and the relationship of depression symptoms to level of cognitive functioning in older persons. Am J Geriatr Psychiatry. 2004;12:211-9.
12. Trichard C, Martinot JL, Alagille M. Time course of prefrontal lobe dysfunction in severely depressed in patients: a longitudinal neuropsychological study. Psychol Med. 1995;25:79-85.
13. Sheline YI, Barch DM, Garcia K, et al. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry. 2006;60:58-65.
14. Lesser IM, Boone KB, Mehringer CM, et al. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry. 1996;153:1280-7.
15. Lichtenberg PA, Ross T, Millis SR, et al. The relationship between depression and cognition in older adults: a cross-validation study. J Gerontol. 1995;50B:P25-P32.
16. Butters MA, Whyte EM, Nebes RD, et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry. 2004;61:587-95.
17. Carr DB, Gray S, Baty J, et al. The value of informant versus individual's complaints of memory impairment in early dementia. Neurology. 2000;55:1724-7.
18. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontology: A Guide to Assessment and Intervention, New York: The Haworth Press, 1986. p 165-73.
19. Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA. 1999;282:1737-44.
20. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measure. 1977;1:385-401.
21. Bruce ML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry. 2002;52:175-84.
22. Cuijpers P, van Straten A, Smit F. Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials. Int J Geriatr Psychiatry. 2006;21:1139-49.
23. Mulsant BH, Alexopoulos GS, Reynolds CF 3rd, et al; PROSPECT Study Group. Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm. Int J Geriatr Psychiatry. 2001;16:585-92.
24. Rush AJ, Fava M, Wisniewski SR, et al; STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25:119-42.
25. Beekman AT, Geerlings SW, Deeg DJ, et al. The natural history of late-life depression: a 6-year prospective study in the community. Arch Gen Psychiatry. 2002;59:605-11.
26. Kessing LV, Andersen PK, Mortensen PB, et al. Recurrence in affective disorder. I. Case register study. Br J Psychiatry. 1998;172:23-8.
27. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry. 2004;185:372-7.
28. Schoevers RA, Smit F, Deeg DJH, et al. Prevention of late-life depression in primary care: do we know where to begin? Am J Psychiatry. 2006;163:1611-21.
29. Koenig HG, Blazer DG. Depression, anxiety, and other mood disorders. In: Cassel CK, Leipzig RM, Cohen HJ, et al. (eds). Geriatric medicine: an evidence-based approach. 4th edition. New York: Springer-Verlag, 2003. p. 1163-83.